A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma
about
Classical and emerging roles of vitamin D in hepatitis C virus infectionActivation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemnessAnalysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk.Novel alkynylphosphonate analogue of calcitriol with potent antiproliferative effects in cancer cells and lack of calcemic activity.Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentSuppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action.Growth and differentiation factor 3 induces expression of genes related to differentiation in a model of cancer stem cells and protects them from retinoic acid-induced apoptosis.Pharmacotherapy of hepatocellular carcinoma.Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial.Resurgence of vitamin D: Old wine in new bottleMechanistic Effects of Calcitriol in Cancer BiologyPrevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature.Theoretical basis of a beneficial role for vitamin D in viral hepatitis.Vitamin D and cancer: clinical aspects.Potent 19-norvitamin D analogs for prostate and liver cancer therapyVitamin d and its role in cancer and immunity: a prescription for sunlight.Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.Mechanism of UV-related carcinogenesis and its contribution to nevi/melanomaVitamin D receptor signaling and pancreatic cancer cell EMT.Vitamin D and human health: lessons from vitamin D receptor null mice.Hepatic stem cells and transforming growth factor β in hepatocellular carcinomaCovalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: structural and biochemical implications.PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.The future of vitamin D analogs.The role of vitamin D in cancer prevention and treatment.Hepatocellular carcinoma and vitamin D: a review.Immunomodulation using agonists and antagonists: potential clinical applications.The role of vitamin D in cancer prevention and treatment.Current progress in using vitamin D and its analogs for cancer prevention and treatment.Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?Vitamin D in cancer chemoprevention.19-Norvitamin D analogs for breast cancer therapy.Vitamin D analog EB1089 induces apoptosis in a subpopulation of SGC-7901 gastric cancer cells through a mitochondrial-dependent apoptotic pathway.BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents.Circulating CD147 predicts mortality in advanced hepatocellular carcinoma.The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer.E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations.
P2860
Q24561964-8148FE7E-2FC7-4F09-A38F-84C6E4115D49Q27346674-05A85B4D-0C84-48E9-9ABA-0001C1AF2233Q33503237-12AE9CD8-EA03-41CA-9699-D6128A825D8DQ33598730-20BC9CDD-4C9A-4F63-804A-0EC16F125CFDQ33802601-835E8A81-FC5C-479C-A24E-7E649EC5ED57Q34621641-E02D7EF6-0495-485C-A8C7-647B77A5C32CQ34755326-F9C94DDF-30CB-4C86-9EBC-1728E112A386Q34756280-76C68356-3E64-4660-911D-81151ECDF3A5Q34778161-7C7E7AB8-9067-48FC-894F-18224D6A9B92Q34947381-B43A4909-618E-4747-9C44-EB172CF5DE06Q35593957-D3DEB847-446C-41C6-8EBB-070DFD5BC950Q35621231-6EF558E3-C54C-4A4E-BD8D-680B396B65DAQ35806866-1A01DCBD-AE75-49F0-915E-D1B467E98CAFQ35809076-05980748-7EE9-4043-B815-2C7027D19F1CQ36230495-34BD9E36-202B-4AEA-B10C-070056259AF6Q36316676-06EE0A23-6D74-4CA0-8D8B-04E97DE445CCQ36509508-0CC17777-918D-4CC2-9AEC-7F98897F1D76Q36682230-8D320B4C-ED3B-4E50-80D5-C5D64694ABABQ36824458-29D27019-5533-45CB-B6D7-38E18C2A22BFQ36843499-E483A38F-FE50-4185-8511-10D092DEAFCFQ36930745-4DEC63B9-8EE9-4FAB-8B94-2120D6811541Q36935182-4FF30F84-915C-485E-AC48-2CECD3BA14A5Q36973933-165B571A-BD9A-49BF-934A-BAC388664DD2Q37099380-3E5E9D11-9F3B-4BA1-B00F-3685A304ACF0Q37226982-CF3DFD12-061C-4F2B-B47D-C1A13D8AF3DCQ37632735-D19FB9F8-57A0-4306-945C-E3778ABCD55BQ37695300-3DBF1263-2DA3-45E0-9C43-BCA238886BE3Q37761548-D1291466-8C3A-44D5-BD1F-9C20FC7798EDQ37924314-1E480FC4-AE9F-4DB8-9D42-69ECA9EAB18EQ37965728-CD97B925-9C62-49A5-A582-0EDFF32A753DQ38004753-D85FEB81-F59D-451E-9A56-CB27B0136B4EQ38020247-4513849D-C66A-47D6-BD34-78F4542AF3E8Q38090585-75879DDF-A607-41C2-B199-AC78F8B28AB0Q38412880-9FAE94B7-AC07-4C6A-A4B3-B79BAEB401E1Q38445909-080DB78C-B0A9-4EA0-B26A-24D4E34CE74BQ39085353-B11D4B0F-C8A1-4D03-92C6-72178F75B872Q39381021-7CC3E3EA-9127-4BB3-BAC5-159D9F986EEEQ40602159-1081653B-C7EE-4C77-9212-C283609B5BC5Q45025548-307868B2-B619-44D6-AD5C-A4E78FC0555FQ46735000-04961162-864F-4187-98AA-60B293A996F8
P2860
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
A phase II study of the vitami ...... rable hepatocellular carcinoma
@ast
A phase II study of the vitami ...... rable hepatocellular carcinoma
@en
type
label
A phase II study of the vitami ...... rable hepatocellular carcinoma
@ast
A phase II study of the vitami ...... rable hepatocellular carcinoma
@en
prefLabel
A phase II study of the vitami ...... rable hepatocellular carcinoma
@ast
A phase II study of the vitami ...... rable hepatocellular carcinoma
@en
P2093
P2860
P356
P1476
A phase II study of the vitami ...... rable hepatocellular carcinoma
@en
P2093
F Burcharth
J Bach Hansen
K J Hamberg
O Rosmorduc
S Erlinger
T R J Evans
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601104
P407
P577
2003-07-01T00:00:00Z